CT-based prediction of EGFR mutation subtypes and TP53 co-mutation status in lung adenocarcinoma
Background Epidermal growth factor receptor (EGFR) mutation status is a key determinant of targeted treatment in lung adenocarcinoma, whereas co-occurring TP53 alterations may further affect therapeutic response and prognosis. This study aimed to develop a noninvasive CT-based approach for predicting EGFR mutation subt...